Jiangsu Mole Bioscience Co., Ltd. was formally established, and became one of the first enterprises entering China Medical City.
Established China Medical City R&D center of Zhejiang University(ZJU) in collaboration with ZJU.
Established Jiangsu Molecular Diagnostic Engineering Technology Research Center with the approval of Jiangsu Provincial Government.
Obtained the first domestic ClassⅢ Registration Certificate of enterovirus nucleic acid multiple detection.
Obtained 4 ClassⅢ Registration Certificates of in vitro diagnostic reagent products and 3 invention patents authorized by the state.
Was identified as a "high-tech enterprise" and undertook the national high and new technology development plan (863) project and the national 12th five-year key science and technology project.
Obtained 8 ClassⅢ Registration Certificates of in vitro diagnostic reagents, among which Mycoplasma pneumoniae Nucleic Acid and Antibiotic Resistant Mutation sites Detection kit(Fluorescent Real-time PCR method) is initiated in China.
Obtained 2 ClassⅢ Registration Certificates of in vitro diagnostic reagent products and 1 invention patent authorized by the state.
Established Jiangsu High-throughput Molecular Diagnostic Engineering Center with the approval of Jiangsu Development and Reform Commission.
Was selected as “ the most promising scientific and technological talent entrepreneurial enterprise ” of Jiangsu province.
11 products obtained CE certification.